SCHEMBL20174580

SCHEMBL20174580

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(-c4cccc5c4-c4c(sc6ccccc46)C54c5ccccc5-c5ccccc54)c3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.36
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
LMNA P02545 3/20 0.36
KDM4E B2RXH2 2/20 0.36
NTSR1 P30989 1/20 0.32
ADORA2A P29274 2/20 0.32
ADORA1 P30542 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C19 P33261 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
GLA P06280 1/20 0.32
MAPK10 P53779 1/20 0.32
AGTR1 P30556 2/20 0.30
CYP3A4 P08684 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174642 0.97 MEN1 (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL20174621 0.95 MEN1 (0.37) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL20174608 0.95 MEN1 (0.37) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL20174579 0.94 MEN1 (0.37) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL20174577 0.93 ADORA2A (0.32) MAPTALDH1A1HPGDKDM4EADORA2A
SCHEMBL20174610 0.93 MEN1 (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL20174599 0.91 ALOX5 (0.32) ADORA2AADORA1F9ALOX5
SCHEMBL22326553 0.90 MEN1 (0.36) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL20174595 0.90 MEN1 (0.33) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL20174597 0.89 MEN1 (0.37) MAPTMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG MAPT 811/4885MEN1 611/4885KMT2A 1480/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG MAPT 811/4885MEN1 611/4885KMT2A 1480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.